Rich Gregory oversees the newly formed Genzyme R&D Center within Sanofi’s R&D organization. He is responsible for Genzyme’s discovery and early development of new product candidates for rare diseases and MS.
| Organization Name | Title At Company | Start Date | End Date | |
|---|---|---|---|---|
ProMIS Neurosciences
|
Board Member | Jul 1, 2017 | — | Detail |